- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 73.27M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $20.5M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $27.5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $309.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $376M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.31B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.26B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.86B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.85B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 70.28M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.5M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$29.8M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $676.4M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $708.9M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.67 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.67 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $29.8M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $20.9M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$47.3M |
| Revenue | Q1 2025 · Mar 31, 2024 | $119.1M |